4-Imidazolecarboxylic Acid

4-Imidazolecarboxylic Acid

SCHEMBL1436799

O=C([O-])c1c[nH]cn1.[Li+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of 4-Imidazolecarboxylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Imidazolecarboxylic Acid SCHEMBL31175403 0.78 PTGER1 (0.30)
4-Imidazolecarboxylic Acid SCHEMBL31175400 0.78 PTGER1 (0.30)
SCHEMBL4445528 0.74
4-Imidazolecarboxylic Acid SCHEMBL10564448 0.74
SCHEMBL1270987 0.74
SCHEMBL343264 0.74
Hydrochloric Acid SCHEMBL1049688 0.73 TSHR (0.39)
SCHEMBL13485764 0.71
SCHEMBL10352034 0.70 FEN1 (0.42)
SCHEMBL5688401 0.70 KDM4E (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470502-A1 TETRA-SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR USE AS MDM2 AND/OR MDM4 MODULATORS Novartis AG (CH) 2012-07-04 EP disclosed
WO-2011023677-A1 TETRA-SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR USE AS MDM2 AND/OR MDM4 MODULATORS NOVARTIS AG (CH) 2011-03-03 WO disclosed